Helminen M E, Maciver I, Latimer J L, Cope L D, McCracken G H, Hansen E J
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.
Infect Immun. 1993 May;61(5):2003-10. doi: 10.1128/iai.61.5.2003-2010.1993.
A murine immunoglobulin G monoclonal antibody (MAb) raised against outer membrane vesicles of Moraxella catarrhalis 035E was shown to bind to a surface-exposed epitope of a major outer membrane protein of this organism. This outer membrane protein, which had an apparent molecular weight of approximately 80,000 in sodium dodecyl sulfate-polyacrylamide gels, was designated CopB. MAb 10F3, reactive with CopB, bound to a majority (70%) of M. catarrhalis strains tested. More importantly, mice passively immunized with MAb 10F3 exhibited an enhanced ability to clear a bolus challenge of M. catarrhalis from their lungs, a result which suggested that CopB might have potential as a vaccine candidate. The M. catarrhalis gene encoding CopB was cloned in Escherichia coli, and nucleotide sequence analysis of the copB gene indicated that the CopB protein was synthesized with a leader peptide, a finding confirmed by N-terminal amino acid sequence analysis of the mature CopB protein purified from M. catarrhalis 035E. Southern blot analysis showed that chromosomal DNA from seven different M. catarrhalis strains hybridized with a probe comprising the majority of the copB structural gene from strain 035E. Additional data emphasizing the extent of conservation of the CopB protein among M. catarrhalis strains were obtained from Western immunoblot analyses with polyclonal antisera raised against CopB proteins from different M. catarrhalis strains used to probe the recombinant form of the CopB protein from strain 035E. The ability of the CopB protein to function as a target for biologically active antibodies and its apparent conservation among M. catarrhalis strains warrant further investigation of this outer membrane protein as a potential vaccine candidate.
一种针对卡他莫拉菌035E外膜囊泡产生的鼠免疫球蛋白G单克隆抗体(MAb),被证明能与该菌主要外膜蛋白的一个表面暴露表位结合。这种外膜蛋白在十二烷基硫酸钠 - 聚丙烯酰胺凝胶中的表观分子量约为80,000,被命名为CopB。与CopB反应的单克隆抗体10F3能与所测试的大多数(70%)卡他莫拉菌菌株结合。更重要的是,用单克隆抗体10F3被动免疫的小鼠清除肺部卡他莫拉菌大剂量攻击的能力增强,这一结果表明CopB可能有作为疫苗候选物的潜力。编码CopB的卡他莫拉菌基因在大肠杆菌中克隆,对copB基因的核苷酸序列分析表明CopB蛋白是由一个前导肽合成的,从卡他莫拉菌035E纯化的成熟CopB蛋白的N端氨基酸序列分析证实了这一发现。Southern印迹分析表明,来自七种不同卡他莫拉菌菌株的染色体DNA与包含035E菌株copB结构基因大部分的探针杂交。通过用针对不同卡他莫拉菌菌株的CopB蛋白产生的多克隆抗血清进行Western免疫印迹分析,以探测035E菌株CopB蛋白的重组形式,获得了更多强调CopB蛋白在卡他莫拉菌菌株间保守程度的数据。CopB蛋白作为生物活性抗体靶点的功能及其在卡他莫拉菌菌株间的明显保守性,值得对这种外膜蛋白作为潜在疫苗候选物进行进一步研究。